Loading
Sentiment · FY2026 Q2
As of FY2026 Q1, the Tellvest earnings-call sentiment score for Danaher Corporation (DHR) is 7/10.
Danaher posted Q1 sales of $6.0 billion with core revenue up 0.5% (including a 2.5% respiratory headwind) and adjusted EPS of $2.06, up 9.5%. Full-year adjusted EPS guidance was raised to $8.35-8.55 while the Masimo acquisition advanced the acute care strategy. Bioprocessing equipment orders inflected positive, China recovery broadened across the portfolio, and operating margin expanded on DBS cost savings with free cash flow conversion at 105%.
Scored from Danaher Corporation’s FY2026 Q1 earnings call. The newest quarter is available with Tellvest Pro.
Full Pro access for 30 days when you create a free account. No credit card required.
All prior quarters are free.
On August 3, 2026, the company announced that, in connection with Ms. Sawyer Montgomery's succession, Rainer M. Blair will cease serving as President and CEO and will resign from the Board and its Executive, Finance and Science & Technology Committees. Under a transition letter agreement, Blair continues as Senior Advisor and a non-officer employee through December 31, 2026, then serves as a consultant through March 31, 2027 at monthly fees equal to his current base salary rate.
| Quarter | Revenue | Rev YoY | EPS | EPS YoY | Gross margin | Op margin | Net margin | FCF |
|---|---|---|---|---|---|---|---|---|
| FY2024 Q4 | $6.54B | +2.1% | $1.49 | +2.8% | 59.5% | 26.7% | 16.6% | $1.50B |
| FY2025 Q1 | $5.74B | -0.9% | $1.32 | -9.0% | 61.2% | 22.2% | 16.6% | $1.05B |
| FY2025 Q2 | $5.94B | +3.4% | $0.77 | -36.9% | 66.6% | 20.1% | 9.3% | $1.09B |
| FY2025 Q3 | $6.05B | +4.4% | $1.27 | +13.4% | 58.2% | 19.1% | 15.0% | $1.37B |
| FY2025 Q4 | $6.84B | +4.6% | $1.68 | +12.8% | 58.0% | 22.0% | 17.5% | $1.75B |
| FY2026 Q1 | $5.95B | +3.7% | $1.45 | +9.8% | 60.3% | 22.6% | 17.3% | $1.08B |
| FY2026 Q2 | $6.26B | +5.5% | $1.23 | +59.7% | 57.6% | 18.0% | 13.9% | $1.26B |